Concepedia

Author

Farid El Hajbi

Centre Oscar Lambret

Also Known As

Antoine Adenis, El Hajbi, Farid, F El Hajbi, F. El Hajbi, F. El hajbi, Farid EL Hajbi, Farid El Hajbi, Farid El Hajbi

87

Publications

3.2K

Citations

20

H-Index

21

Concepts

All Affiliations

Centre Oscar LambretInsermCentre Hospitalier Universitaire de ReimsUniversité de Reims Champagne-ArdenneSorbonne Université
FE

About

Farid El Hajbi is an author at Centre Oscar Lambret specializing in cancer therapeutics, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

390

2

Health Sciences

4

4

112

3

Gastroenterology

2

2

56

4

Immunology

2

2

28

5

Geriatrics

1

1

38

Farid El Hajbi

×

27

Publications

2.8K

Citations

20

H-Index

YearCitations

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne,

The Lancet Oncology

2021

1.2K

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Yuichiro� Doki, Jaffer A. Ajani, Ken Kato,

UCL Discovery (University College London)

2022

532

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Stéfano Kim, Éric François, Thierry André,

The Lancet Oncology

2018

140

Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study.

Ian Chau, Yuichiro� Doki, Jaffer A. Ajani,

Journal of Clinical Oncology

2021

110

Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial

Pascal Hammel, Fabienne Portales, Laurent Mineur,

European Journal of Cancer

2019

106

Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial

Alice Bernard‐Tessier, Emmanuelle Jeannot, David Guenat,

Clinical Cancer Research

2018

90

Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study

David Laharie, Samir Mesli, Farid El Hajbi,

Alimentary Pharmacology & Therapeutics

2011

86

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Thomas Aparicio, Olivier Bouché, E. Maillard,

Annals of Oncology

2017

76

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial

Mathieu Messager, X. Mirabel, Emmanuelle Tresch,

BMC Cancer

2016

40

Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis

Capucine Baldini, Anne Escande, Olivier Bouché,

Pancreatology

2016

39

Page 1